Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Pixomondo on the deal. Pixomondo announced its acquisition by Sony Pictures Entertainment from Mayfair Equity Partners. The acquisition of Pixomondo, alongside Sony Pictures Imageworks...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Due Dilly on the deal. Due Dilly announced its acquisition by Beckett. Due Dilly is an app and marketplace for trading sports card collectibles....
You must be a Standard 1 Year member to access this content.
Goodwin advised Underdog Sports Inc. on the deal. Underdog Sports Inc. announced its $35 million Series B round of fundraising valuing the company at $485 million. The...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Innovium on the deal. Innovium announced its acquisition by Marvell Technology (NASDAQ: MRVL) in an all-stock transaction, which closed on October 5, 2021. Under...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Absci, while Latham & Watkins represented the underwriters in the offering. Absci Corporation (Absci), the synthetic biology company unlocking the potential of proteins...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP and Mintz advised Stavvy on the deal. Stavvy announced its $40+ million Series A funding round. The round was led by Morningside Technology Ventures....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised ElevateBio on the deal. ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, announced it...
You must be a Standard 1 Year member to access this content.
